Monoclonal Antibody Custom Service Market is predicted to reach USD 1.172631837 billion at a CAGR of ~5.90% during the forecast period

Market Research Future (MRFR) has published a cooked research report on the “global monoclonal antibody custom service market” that contains the information from 2023 to 2032. The monoclonal antibody custom service market is expected to register a CAGR of 5.90% during the forecast period of 2023 to 2032.

Monoclonal antibodies, which are produced from a single clone and may be grown forever, are extremely specific for a specific area of the body. Monoclonal antibodies distinguish between certain epitopes by binding to antigens, which offers defense against pathogenic organisms. Several factors are driving market growth, including increased R&D activities and investments, a high prevalence of diseases such as cardiovascular disease, infectious diseases, and cancer, and an increase in demand for personalized medicine in protein therapeutics. Furthermore, companies have begun to make efforts, including custom monoclonal antibody services, such as increasing monoclonal antibody product approvals and research funding.

Increasing investment in research & development and rising prevalence of chronic and infectious diseases are projected to boost the growth of the monoclonal antibody custom service market

Segment Analysis

The global monoclonal antibody custom service market has been divided based on source, type, and application, and end user.

On the basis of source, the market is segmented into rat/mouse custom monoclonal antibody, rabbit custom monoclonal antibody, camelid custom antibodies, and others.

On the basis of type, the market is segmented into primary antibodies and secondary antibodies.

Based on application, the global market has been diagnostic application, therapeutic application, and research application.

Based on end user, the global monoclonal antibody custom service market has been segmented into hospitals, research & academic laboratories, pharmaceutical & biotechnology companies, and others.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Monoclonal Antibody Custom Service Market Research Report

Regional Analysis

The global monoclonal antibody custom service market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World market comprises of Middle East, Africa, and Latin America.

The North America is expected to dominate with the largest market share due to factors Key factors attributed to its large market share include developed healthcare infrastructure, growing public and private financing and research grants for producing safe and effective custom antibody products, and the presence of many market players in the region.

Europe held a significant share in the global market. Owing to the extensive research and product approvals in antibody therapies and a growing number of cases of chronic and neurological disorders are the major factors driving the market growth in Europe.

Asia-Pacific is expected to be the fastest-growing market in monoclonal antibody custom service market, due to many mergers and partnerships are taking place amongst academic institutes and biotechnology companies within and outside of China. The rising prevalence of cancer, and the growing adoption of monoclonal custom antibody treatments in the region, are likely to drive the market’s growth.

The rest of the world accounted for the lowest market share due to limited access, and inadequate healthcare infrastructure. Furthermore, the increasing cancer rates in the Middle East region show promising applications and growth opportunities for vendors operating in the custom antibody market.

Key Players

MRFR recognizes the following companies as the key players in the global monoclonal antibody custom service market— Thermo Fisher Scientific Inc. (US), GenScript (US), Abcam plc (UK), Creative Biolabs (US), and Sino Biological, Inc. (China).

Key Findings of the Study

• The North America region accounted for the largest share of the global market, owing to the developed healthcare infrastructure, and growing public and private financing.


• Based on type, the secondary antibodies segment held the largest market in 2021, with a market share of 73.47%, reaching a market value of USD 217.77 million by 2030.